MasoonDarou Pharmaceutical Company (Private Joint Stock Company) was founded in 2007 as a knowledge-based company. Through the acquisition of technical knowledge, the company has been successful in producing biotechnological pharmaceuticals and vaccines for human consumption. It also uses cutting-edge technologies to provide innovative medications to improve public health and prevent diseases.
MasoonDarou Pharmaceutical Company
MasoonDarou
Adorateb is the distributor of MasoonDarou products in Iran, contact for more information
MasoonDarou Co.
MasoonDarou is the first and only pharmaceutical company in Iran that produces monovalent and polyvalent antitoxins of Clostridium botulinum, Haemophilus influenzae type B conjugate vaccine (MAS-Hib VAC®️), and Clostridium botulinum toxin type A 500 U (MASPORT®️500). MasoonDarou Co. produces these products in accordance with European and American standards. The production capacity of this company far exceeds the needs of the country. Currently, MasoonDarou Co.’s products not only wholly satisfy national demands but are also sold in Asia, Europe, America, Africa, and Oceania, where their superior quality has won them great acknowledgment.